BruceJosephRothMD
Oncology • Saint Louis, MOGenitourinary Oncology, Hematologic Oncology
Professor of Medicine Washington University in St. Louis
Dr. Roth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5225 Mid America Plz
# Dv
Saint Louis, MO 63129Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1986- Indiana University School of MedicineResidency, Internal Medicine, 1980 - 1983
- Indiana University School of MedicineInternship, Internal Medicine, 1980 - 1981
Saint Louis University School of MedicineClass of 1980
Certifications & Licensure
MO State Medical License 2010 - 2025
TN State Medical License 1999 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Join now to see all
Clinical Trials
- Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract Start of enrollment: 1997 Jul 15
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium Start of enrollment: 1998 Dec 03
- Combination Chemotherapy in Treating Patients With Bladder Cancer Start of enrollment: 1999 Apr 02
- Join now to see all
Publications & Presentations
PubMed
- 652 citationsCabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trialToni K. Choueiri, Bernard Escudier, Thomas Powles, Nizar M. Tannir, Paul N. Mainwaring
The Lancet. Oncology. 2016-07-01 - 200 citationsComparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinomaMatthew D. Galsky, G. J. Chen, William Oh, Joaquim Bellmunt, Bruce J. Roth
Annals of Oncology. 2012-02-01 - 87 citationsCastration-resistant prostate cancerMichael S. Cookson, Bruce J. Roth, Philipp Dahm, Christine Engstrom, Stephen J. Freedland
European Urology. 2013-08-01
Press Mentions
Collaboration Between Rheumatologists, Primary Care Reduces Delay in Axial SpA DiagnosisAugust 4th, 2021- VA Pathologist Created Scoring System That Predicts Aggressiveness of Prostate CancerNovember 5th, 2020
New Drug May Boost Survival for Advanced Prostate Cancer Patients: Study - US NewsJune 2nd, 2014- Join now to see all
Committees
- Member, Castration-resistant Prostate Cancer Guidelines Panel, AUA 2015 - 2018
- Chairman, Oncology Drug Advisory Committee of the FDA 2014 - 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
